Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06455514 · ClinicalTrials.gov registry record · Phase 1
Post-CA Neuroprotection With Magnesium
A Phase 1 study of Cardiac Arrest and Return of Spontaneous Circulation, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 178
- Enrollment target
- 1
- Study location
NCT06455514 is a Phase 1 study of Cardiac Arrest and Return of Spontaneous Circulation that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 178 participants, below the 1,474-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06455514, a Phase 1 study of Cardiac Arrest and Return of Spontaneous Circulation, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 178 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot interventional study is to collect preliminary data on administering magnesium sulfate as a neuroprotective medication in patients who achieved Return of Spontaneous Circulation (ROSC) following Cardiac Arrest (CA). The primary aims are to assess the feasibility and safety of administering magnesium and measure serum markers of neuronal injury at prespecified time points in the post-cardiac arrest period. Because this is a pilot study with a limited sample size, the primary objective is to evaluate the precision and stability of the collected measures to inform the design and formal analysis in a larger trial.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Magnesium Sulfate
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2025-03-25 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06455514
The ClinicalTrials.gov registry entry for NCT06455514 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,474-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (88% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiac Arrest appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT06455514 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06455514 about?
NCT06455514 is a clinical study titled "Post-CA Neuroprotection With Magnesium". The purpose of this pilot interventional study is to collect preliminary data on administering magnesium sulfate as a neuroprotective medication in patients who achieved Return of Spontaneous Circulation (ROSC) following Cardiac Arrest (CA). The primary aims are to assess the feasibility and safety ...
What is the current status of trial NCT06455514?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 178 participants. The study started on 2025-03-25. Estimated completion is 2026-06-30.
What conditions does trial NCT06455514 study?
This clinical trial studies the following conditions: Cardiac Arrest, Return of Spontaneous Circulation.
What interventions are being tested in trial NCT06455514?
The interventions under investigation include: Saline (DRUG), Magnesium Sulfate (DRUG).
Who is sponsoring clinical trial NCT06455514?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06455514 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
-
Packed Red Blood Cell Transfusion During Cardiac Arrest
RECRUITING · Phase 1
-
Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
COMPLETED · Phase 1
-
Washington Study of Hemofiltration After Out-of-Hospital Cardiac Arrest
COMPLETED · Phase 1
-
Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
COMPLETED · Phase 1
-
Reoxygenation After Cardiac Arrest II (REOX II Study)
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.